Every substance named in the federal drug schedules at 21 CFR 1308.11-1308.15, with the schedule it sits in, its DEA Controlled Substances Code Number, the class it is listed under, and the exact paragraph of the regulation the entry comes from. One record is one substance at one paragraph, quoted from the regulation itself. A drug can sit in more than one schedule at the same time, and the difference is usually the preparation rather than the drug: codeine is Schedule II on its own, Schedule III in a limited-strength compound, and Schedule V at not more than 200 milligrams per 100 millilitres. Each of those is a separate record, so the answer is not silently collapsed into whichever listing came first. Marijuana is split the same way: Schedule I as a plant, and Schedule III in an FDA-approved product or when subject to a state medical marijuana licence. Substances placed in Schedule I on an emergency temporary basis carry the date that placement runs until. Two limits are worth knowing: the anabolic steroids in 1308.13(f) share a single code number for the whole class, so individual steroids are published with no code rather than an invented one, and a few entries print XXXX where a code would go. Answers what schedule a given drug is in, whether marijuana is Schedule I or III, what the DEA code number for a substance is, and when a temporary listing expires.

Federal regulatory text (21 CFR), not copyrightable

Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9097

**Temporary listing expires:** Aug. 27, 2028

> adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028

**CFR citation:** 21 CFR 1308.11(h)(92)

> (92) 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968) | 9097 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro brorphine; SR-14968) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-[1-(2-thienyl)cyclohexyl]pyrrolidine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7473

**CFR citation:** 21 CFR 1308.11(d)(35)

> (35) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine | 7473 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-[1-(2-thienyl)cyclohexyl]pyrrolidine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7552

**CFR citation:** 21 CFR 1308.11(d)(105)

> (105) 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone) | 7552 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (other names: dipentylone; N,N-dimethylpentylone) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7549

**CFR citation:** 21 CFR 1308.11(d)(101)

> (101) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) | 7549 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one (other names: eutylone; bk-EBDB) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7547

**CFR citation:** 21 CFR 1308.11(d)(80)

> (80) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) | 7547 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7541

**CFR citation:** 21 CFR 1308.11(d)(62)

> (62) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) | (7541) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7542

**CFR citation:** 21 CFR 1308.11(d)(64)

> (64) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) | (7542) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone, bk-MBDP) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7089

**CFR citation:** 21 CFR 1308.11(d)(83)

> (83) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) | 7089 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7014

**CFR citation:** 21 CFR 1308.11(d)(93)

> (93) (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144) | 7014 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (other name: FUB-144) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1245

**CFR citation:** 21 CFR 1308.11(d)(88)

> (88) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) | (1245) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7011

**CFR citation:** 21 CFR 1308.11(d)(49)

> (49) [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) | (7011) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

[1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7024

**CFR citation:** 21 CFR 1308.11(d)(71)

> (71) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) | (7024) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7201

**CFR citation:** 21 CFR 1308.11(d)(108)

> (108) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) | 7201 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7083

**CFR citation:** 21 CFR 1308.11(d)(92)

> (92) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) | 7083 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names: 5F-CUMYL-PINACA; SGT-25) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7085

**CFR citation:** 21 CFR 1308.11(d)(85)

> (85) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) | 7085 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(4)

> (4) 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(3)

> (3) 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-androstenedione (5α-androst-1-en-3,17-dione)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(7)

> (7) 1-androstenedione (5α-androst-1-en-3,17-dione);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-androstenedione (5α-androst-1-en-3,17-dione) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Δ1-dihydrotestosterone (a.k.a. “1-testosterone”) (17β-hydroxy-5α-androst-1-en-3-one)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(24)

> (24) Δ1-dihydrotestosterone (a.k.a. “1-testosterone”) (17β-hydroxy-5α-androst-1-en-3-one);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Δ1-dihydrotestosterone (a.k.a. “1-testosterone”) (17β-hydroxy-5α-androst-1-en-3-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1258

**CFR citation:** 21 CFR 1308.11(d)(67)

> (67) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) | (1258) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7144

**CFR citation:** 21 CFR 1308.11(d)(48)

> (48) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) | (7144) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7118

**CFR citation:** 21 CFR 1308.11(d)(107)

> (107) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) | 7118 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-phenylcyclohexylamine

**Schedule:** Schedule II

> § 1308.12 Schedule II.

**Listed under:** Immediate precursors

> (g) Immediate precursors.

**DEA code number:** 7460

**CFR citation:** 21 CFR 1308.12(g)(2)(i)

> (i) 1-phenylcyclohexylamine | 7460 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-phenylcyclohexylamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 1-piperidinocyclohexanecarbonitrile (PCC)

**Schedule:** Schedule II

> § 1308.12 Schedule II.

**Listed under:** Immediate precursors

> (g) Immediate precursors.

**DEA code number:** 8603

**CFR citation:** 21 CFR 1308.12(g)(2)(ii)

> (ii) 1-piperidinocyclohexanecarbonitrile (PCC) | 8603 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

1-piperidinocyclohexanecarbonitrile (PCC) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 13β-ethyl-17β-hydroxygon-4-en-3-one

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(31)

> (31) 13β-ethyl-17β-hydroxygon-4-en-3-one;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

13β-ethyl-17β-hydroxygon-4-en-3-one — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17β-hydroxy-androstano[2,3-d]isoxazole

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(40)

> (40) 17β-hydroxy-androstano[2,3-d]isoxazole;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17β-hydroxy-androstano[2,3-d]isoxazole — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17β-hydroxy-androstano[3,2-c]isoxazole

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(41)

> (41) 17β-hydroxy-androstano[3,2-c]isoxazole;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17β-hydroxy-androstano[3,2-c]isoxazole — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) (a.k.a. “17-α-methyl-1-testosterone”)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(60)

> (60) 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) (a.k.a. “17-α-methyl-1-testosterone”);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) (a.k.a. “17-α-methyl-1-testosterone”) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-3α,17β-dihydroxy-5α-androstane

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(56)

> (56) 17α-methyl-3α,17β-dihydroxy-5α-androstane;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-3α,17β-dihydroxy-5α-androstane — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-3β,17β-dihydroxy-5α-androstane

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(55)

> (55) 17α-methyl-3β,17β-dihydroxy-5α-androstane;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-3β,17β-dihydroxy-5α-androstane — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-3β,17β-dihydroxyandrost-4-ene

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(57)

> (57) 17α-methyl-3β,17β-dihydroxyandrost-4-ene;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-3β,17β-dihydroxyandrost-4-ene — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(58)

> (58) 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-5α-androstan-17β-ol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(51)

> (51) 17α-methyl-5α-androstan-17β-ol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-5α-androstan-17β-ol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-androst-2-ene-3,17β-diol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(54)

> (54) 17α-methyl-androst-2-ene-3,17β-diol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-androst-2-ene-3,17β-diol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-androsta-1,4-diene-3,17β-diol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(50)

> (50) 17α-methyl-androsta-1,4-diene-3,17β-diol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-androsta-1,4-diene-3,17β-diol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 17α-methyl-androstan-3-hydroxyimine-17β-ol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(52)

> (52) 17α-methyl-androstan-3-hydroxyimine-17β-ol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

17α-methyl-androstan-3-hydroxyimine-17β-ol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(37)

> (37) 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(69)

> (69) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 19-nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(66)

> (66) 19-nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

19-nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 19-nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(65)

> (65) 19-nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

19-nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 19-nor-4-androstenedione (estr-4-en-3,17-dione)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(70)

> (70) 19-nor-4-androstenedione (estr-4-en-3,17-dione);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

19-nor-4-androstenedione (estr-4-en-3,17-dione) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 19-nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(68)

> (68) 19-nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

19-nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 19-nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(67)

> (67) 19-nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

19-nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 19-nor-5-androstenedione (estr-5-en-3,17-dione)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(71)

> (71) 19-nor-5-androstenedione (estr-5-en-3,17-dione);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

19-nor-5-androstenedione (estr-5-en-3,17-dione) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(27)

> (27) 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9770

**Temporary listing expires:** Oct. 15, 2027

> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027

**CFR citation:** 21 CFR 1308.11(h)(79)

> (79) 2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene) | 9770 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2-((2,3-dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: Ethyleneoxynitazene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9765

**CFR citation:** 21 CFR 1308.11(b)(42)

> (42) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) | 9765 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (Other names: etodesnitazene; etazene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9767

**Temporary listing expires:** Oct. 15, 2027

> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027

**CFR citation:** 21 CFR 1308.11(h)(81)

> (81) 2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene) | 9767 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2-(4-ethoxybenzyl)-5-methyl-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: 5-methyl etodesnitazene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9768

**Temporary listing expires:** Oct. 15, 2027

> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027

**CFR citation:** 21 CFR 1308.11(h)(82)

> (82) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene) | 9768 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N-ethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-desethyl etonitazene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9771

**Temporary listing expires:** Oct. 15, 2027

> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027

**CFR citation:** 21 CFR 1308.11(h)(84)

> (84) 2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene) | 9771 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-dimethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N,N-dimethylamino etonitazene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7509

**CFR citation:** 21 CFR 1308.11(d)(38)

> (38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) | 7509 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7508

**CFR citation:** 21 CFR 1308.11(d)(39)

> (39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) | 7508 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7524

**CFR citation:** 21 CFR 1308.11(d)(46)

> (46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) | 7524 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7521

**CFR citation:** 21 CFR 1308.11(d)(45)

> (45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) | 7521 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7517

**CFR citation:** 21 CFR 1308.11(d)(44)

> (44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) | 7517 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3′,4′-methylenedioxynitazene)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9766

**Temporary listing expires:** Oct. 15, 2027

> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027

**CFR citation:** 21 CFR 1308.11(h)(80)

> (80) 2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3′,4′-methylenedioxynitazene) | 9766 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(2-(benzodioxol-5-ylmethyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other names: Methylenedioxynitazene; 3′,4′-methylenedioxynitazene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2α,3α-epithio-17α-methyl-5α-androstan-17β-ol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(29)

> (29) 2α,3α-epithio-17α-methyl-5α-androstan-17β-ol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2α,3α-epithio-17α-methyl-5α-androstan-17β-ol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7536

**CFR citation:** 21 CFR 1308.11(d)(57)

> (57) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) | (7536) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7519

**CFR citation:** 21 CFR 1308.11(d)(40)

> (40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) | 7519 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7537

**CFR citation:** 21 CFR 1308.11(d)(56)

> (56) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) | (7537) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9758

**CFR citation:** 21 CFR 1308.11(b)(78)

> (78) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) | 9758 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino etonitazene; etonitazepyne) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7385

**CFR citation:** 21 CFR 1308.11(d)(42)

> (42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) | 7385 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7518

**CFR citation:** 21 CFR 1308.11(d)(41)

> (41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) | 7518 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7538

**CFR citation:** 21 CFR 1308.11(d)(55)

> (55) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) | (7538) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9772

**Temporary listing expires:** Oct. 15, 2027

> adding paragraphs (h)(79) through (85), effective Oct. 15, 2025, until Oct. 15, 2027

**CFR citation:** 21 CFR 1308.11(h)(85)

> (85) 2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene) | 9772 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(4-isopropoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole, its isomers, esters, ethers, salts, and salts of isomers, esters and ethers (Other name: N-pyrrolidino isotonitazene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7532

**CFR citation:** 21 CFR 1308.11(d)(43)

> (43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) | 7532 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9762

**CFR citation:** 21 CFR 1308.11(b)(79)

> (79) 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne) | 9762 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other names: N-pyrrolidino metonitazene; metonitazepyne) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2,5-dimethoxy-4-ethylamphet-amine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7399

**CFR citation:** 21 CFR 1308.11(d)(5)

> (5) 2,5-dimethoxy-4-ethylamphet-amine | 7399 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2,5-dimethoxy-4-ethylamphet-amine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7348

**CFR citation:** 21 CFR 1308.11(d)(6)

> (6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) | 7348 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2,5-dimethoxyamphetamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7396

**CFR citation:** 21 CFR 1308.11(d)(4)

> (4) 2,5-dimethoxyamphetamine | 7396 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2,5-dimethoxyamphetamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2′,5′-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9861

**CFR citation:** 21 CFR 1308.11(b)(37)

> (37) 2′,5′-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) | 9861 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2′,5′-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol)

**Schedule:** Schedule IV

> § 1308.14 Schedule IV.

**Listed under:** Narcotic drugs

> (b) Narcotic drugs.

**DEA code number:** 9752

**CFR citation:** 21 CFR 1308.14(b)(3)

> (3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) | 9752 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7286

**CFR citation:** 21 CFR 1308.11(d)(100)

> (100) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) | 7286 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine, MXE) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2′-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2′-fluoro 2-fluorofentanyl)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9855

**CFR citation:** 21 CFR 1308.11(b)(48)

> (48) 2′-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2′-fluoro 2-fluorofentanyl) | 9855 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2′-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2′-fluoro 2-fluorofentanyl) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 7284

**Temporary listing expires:** May 22, 2028

> adding paragraph (h)(87), effective May 22, 2026 through May 22, 2028

**CFR citation:** 21 CFR 1308.11(h)(87)

> (87) 2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK) | 7284 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-Fluorodeschloroketamine, its salts, isomers, and salts of isomers (other name: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one; also known as 2-FDCK) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9664

**CFR citation:** 21 CFR 1308.11(b)(64)

> (64) 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) | 9664 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1259

**CFR citation:** 21 CFR 1308.11(d)(104)

> (104) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone) | 1259 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(methylamino)-1-(3-methylphenyl)propan-1-one (other names: 3-MMC; 3-methylmethcathinone) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 2-(methylamino)-1-phenylpentan-1-one (pentedrone)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1246

**CFR citation:** 21 CFR 1308.11(d)(63)

> (63) 2-(methylamino)-1-phenylpentan-1-one (pentedrone) | (1246) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

2-(methylamino)-1-phenylpentan-1-one (pentedrone) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3α,17β-dihydroxy-5α-androstane

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(26)

> (26) 3α,17β-dihydroxy-5α-androstane;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3α,17β-dihydroxy-5α-androstane — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3β,17β-dihydroxy-5α-androstane

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(25)

> (25) 3β,17β-dihydroxy-5α-androstane;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3β,17β-dihydroxy-5α-androstane — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** [3,2-c]furazan-5α-androstan-17β-ol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(36)

> (36) [3,2-c]furazan-5α-androstan-17β-ol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

[3,2-c]furazan-5α-androstan-17β-ol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** [3,2-c]pyrazole-androst-4-en-17β-ol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(80)

> (80) [3,2-c]pyrazole-androst-4-en-17β-ol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

[3,2-c]pyrazole-androst-4-en-17β-ol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9094

**Temporary listing expires:** Aug. 27, 2028

> adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028

**CFR citation:** 21 CFR 1308.11(h)(94)

> (94) 3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine) | 9094 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3-(3-(1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propanenitrile, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: N-propionitrile chlorphine; cychlorphine) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3,4,5-trimethoxy amphetamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7390

**CFR citation:** 21 CFR 1308.11(d)(14)

> (14) 3,4,5-trimethoxy amphetamine | 7390 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3,4,5-trimethoxy amphetamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3,4-methylenedioxy amphetamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7400

**CFR citation:** 21 CFR 1308.11(d)(10)

> (10) 3,4-methylenedioxy amphetamine | 7400 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3,4-methylenedioxy amphetamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7404

**CFR citation:** 21 CFR 1308.11(d)(12)

> (12) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA | 7404 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)-phenethylamine, N-ethyl MDA, MDE, MDEA — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3,4-Methylenedioxy-N-methylcathinone (Methylone)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7540

**CFR citation:** 21 CFR 1308.11(d)(47)

> (47) 3,4-Methylenedioxy-N-methylcathinone (Methylone) | 7540 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3,4-Methylenedioxy-N-methylcathinone (Methylone) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3,4-methylenedioxymethamphetamine (MDMA)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7405

**CFR citation:** 21 CFR 1308.11(d)(11)

> (11) 3,4-methylenedioxymethamphetamine (MDMA) | 7405 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3,4-methylenedioxymethamphetamine (MDMA) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3,4-methylenedioxypyrovalerone (MDPV)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7535

**CFR citation:** 21 CFR 1308.11(d)(37)

> (37) 3,4-methylenedioxypyrovalerone (MDPV) | 7535 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3,4-methylenedioxypyrovalerone (MDPV) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3-fluoro-N-methylcathinone (3-FMC)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1233

**CFR citation:** 21 CFR 1308.11(d)(66)

> (66) 3-fluoro-N-methylcathinone (3-FMC) | (1233) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3-fluoro-N-methylcathinone (3-FMC) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9860

**CFR citation:** 21 CFR 1308.11(b)(50)

> (50) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) | 9860 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3β-hydroxy-estra-4,9,11-trien-17-one

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(42)

> (42) 3β-hydroxy-estra-4,9,11-trien-17-one;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3β-hydroxy-estra-4,9,11-trien-17-one — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7457

**CFR citation:** 21 CFR 1308.11(d)(109)

> (109) 3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP) | 7457 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3-methoxyphencyclidine (Other names: 1-(1-(3-methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9813

**CFR citation:** 21 CFR 1308.11(b)(65)

> (65) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) | 9813 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9833

**CFR citation:** 21 CFR 1308.11(b)(66)

> (66) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) | 9833 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Stimulants

> (f) Stimulants.

**DEA code number:** 1595

**CFR citation:** 21 CFR 1308.11(f)(5)

> (5) 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) | 1595 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-androstenediol (3β,17β-dihydroxy-androst-4-ene)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(5)

> (5) 4-androstenediol (3β,17β-dihydroxy-androst-4-ene);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-androstenediol (3β,17β-dihydroxy-androst-4-ene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-androstenedione (androst-4-en-3,17-dione)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(8)

> (8) 4-androstenedione (androst-4-en-3,17-dione);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-androstenedione (androst-4-en-3,17-dione) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-anilino-N-phenethylpiperidine (ANPP)

**Schedule:** Schedule II

> § 1308.12 Schedule II.

**Listed under:** Immediate precursors

> (g) Immediate precursors.

**DEA code number:** 8333

**CFR citation:** 21 CFR 1308.12(g)(3)(i)

> (i) 4-anilino-N-phenethylpiperidine (ANPP) | 8333 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-anilino-N-phenethylpiperidine (ANPP) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-bromo-2,5-dimethoxy-amphetamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7391

**CFR citation:** 21 CFR 1308.11(d)(2)

> (2) 4-bromo-2,5-dimethoxy-amphetamine | 7391 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-bromo-2,5-dimethoxy-amphetamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-Bromo-2,5-dimethoxyphenethylamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7392

**CFR citation:** 21 CFR 1308.11(d)(3)

> (3) 4-Bromo-2,5-dimethoxyphenethylamine | 7392 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-Bromo-2,5-dimethoxyphenethylamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(18)

> (18) 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(19)

> (19) 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-chloro-17α-methyl-androst-4-ene-3β,17β-diol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(17)

> (17) 4-chloro-17α-methyl-androst-4-ene-3β,17β-diol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-chloro-17α-methyl-androst-4-ene-3β,17β-diol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(16)

> (16) 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4′-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-α-PVP; 4′-chloro-α-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7443

**CFR citation:** 21 CFR 1308.11(d)(99)

> (99) 4′-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-α-PVP; 4′-chloro-α-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) | 7443 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4′-Chloro-alpha-pyrrolidinovalerophenone (Other names: 4-chloro-α-PVP; 4′-chloro-α-pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1239

**CFR citation:** 21 CFR 1308.11(d)(106)

> (106) 4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) | 1239 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-Chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2-(methylamino)propan-1-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-dihydrotestosterone (17β-hydroxy-androstan-3-one)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(23)

> (23) 4-dihydrotestosterone (17β-hydroxy-androstan-3-one);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-dihydrotestosterone (17β-hydroxy-androstan-3-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-fluoro-N-methylcathinone (4-FMC; flephedrone)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1238

**CFR citation:** 21 CFR 1308.11(d)(65)

> (65) 4-fluoro-N-methylcathinone (4-FMC; flephedrone) | (1238) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-fluoro-N-methylcathinone (4-FMC; flephedrone) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Stimulants

> (f) Stimulants.

**DEA code number:** 1476

**CFR citation:** 21 CFR 1308.11(f)(8)

> (8) 4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine) | 1476 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-Fluoroamphetamine (4-FA, 1-(4-fluorophenyl)propan-2-amine, para-fluoroamphetamine) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9824

**CFR citation:** 21 CFR 1308.11(b)(47)

> (47) 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) | 9824 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(38)

> (38) 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-hydroxy-androst-4-ene-3,17-dione

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(39)

> (39) 4-hydroxy-androst-4-ene-3,17-dione;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-hydroxy-androst-4-ene-3,17-dione — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(43)

> (43) 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-methoxyamphetamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7411

**CFR citation:** 21 CFR 1308.11(d)(7)

> (7) 4-methoxyamphetamine | 7411 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-methoxyamphetamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: α-PiHP; alpha-PiHP)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7551

**CFR citation:** 21 CFR 1308.11(d)(103)

> (103) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: α-PiHP; alpha-PiHP) | 7551 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other names: α-PiHP; alpha-PiHP) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-methyl-2,5-dimethoxy-amphetamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7395

**CFR citation:** 21 CFR 1308.11(d)(9)

> (9) 4-methyl-2,5-dimethoxy-amphetamine | 7395 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-methyl-2,5-dimethoxy-amphetamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9819

**CFR citation:** 21 CFR 1308.11(b)(63)

> (63) 4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) | 9819 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7245

**CFR citation:** 21 CFR 1308.11(d)(96)

> (96) 4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) | 7245 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-Methyl-alpha-ethylaminopentiophenone (Other names: 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4′-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4′-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7446

**CFR citation:** 21 CFR 1308.11(d)(97)

> (97) 4′-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4′-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) | 7446 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4′-Methyl-alpha-pyrrolidinohexiophenone (Other names: MPHP; 4′-methyl-alpha-pyrrolidinohexanophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7498

**CFR citation:** 21 CFR 1308.11(d)(60)

> (60) 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) | (7498) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-methyl-N-ethylcathinone (4-MEC)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1249

**CFR citation:** 21 CFR 1308.11(d)(59)

> (59) 4-methyl-N-ethylcathinone (4-MEC) | (1249) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-methyl-N-ethylcathinone (4-MEC) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 4-methylmethcathinone (Mephedrone)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 1248

**CFR citation:** 21 CFR 1308.11(d)(36)

> (36) 4-methylmethcathinone (Mephedrone) | 1248 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

4-methylmethcathinone (Mephedrone) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9096

**Temporary listing expires:** Aug. 27, 2028

> adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028

**CFR citation:** 21 CFR 1308.11(h)(93)

> (93) 5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018) | 9096 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5,6-dichloro-1-(1-(4-chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: 5,6-dichloro desmethylchlorphine; SR-17018) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5α-androstan-3,17-dione

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(1)

> (1) 5α-androstan-3,17-dione;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5α-androstan-3,17-dione — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5α-androstan-3,6,17-trione

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(2)

> (2) 5α-androstan-3,6,17-trione;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5α-androstan-3,6,17-trione — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5-androstenediol (3β,17β-dihydroxy-androst-5-ene)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(6)

> (6) 5-androstenediol (3β,17β-dihydroxy-androst-5-ene);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5-androstenediol (3β,17β-dihydroxy-androst-5-ene) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5-androstenedione (androst-5-en-3,17-dione)

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(9)

> (9) 5-androstenedione (androst-5-en-3,17-dione);

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5-androstenedione (androst-5-en-3,17-dione) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5-methoxy-3,4-methylenedioxy-amphetamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7401

**CFR citation:** 21 CFR 1308.11(d)(8)

> (8) 5-methoxy-3,4-methylenedioxy-amphetamine | 7401 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5-methoxy-3,4-methylenedioxy-amphetamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7439

**CFR citation:** 21 CFR 1308.11(d)(20)

> (20) 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) | 7439 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7431

**CFR citation:** 21 CFR 1308.11(d)(15)

> (15) 5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT | 7431 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5-methoxy-N,N-dimethyltryptamine Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9763

**CFR citation:** 21 CFR 1308.11(b)(80)

> (80) 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne) | 9763 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino protonitazene; protonitazepyne) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7093

**CFR citation:** 21 CFR 1308.11(d)(116)

> (116) 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151) | 7093 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7220

**CFR citation:** 21 CFR 1308.11(d)(115)

> (115) 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC) | 7220 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol (other names: hexahydrocannabinol, HHC) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 6-bromo-androsta-1,4-diene-3,17-dione

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(13)

> (13) 6-bromo-androsta-1,4-diene-3,17-dione;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

6-bromo-androsta-1,4-diene-3,17-dione — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 6-bromo-androstan-3,17-dione

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(14)

> (14) 6-bromo-androstan-3,17-dione;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

6-bromo-androstan-3,17-dione — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 6α-methyl-androst-4-ene-3,17-dione

**Schedule:** Schedule III

> § 1308.13 Schedule III.

**Listed under:** Anabolic steroids

> (f) Anabolic steroids.

**CFR citation:** 21 CFR 1308.13(f)(53)

> (53) 6α-methyl-androst-4-ene-3,17-dione;

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

6α-methyl-androst-4-ene-3,17-dione — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 9093

**Temporary listing expires:** Aug. 27, 2028

> adding paragraphs (h)(92) through (h)(95), effective Aug. 27, 2026 through Aug. 27, 2028

**CFR citation:** 21 CFR 1308.11(h)(95)

> (95) 8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890) | 9093 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

8-(1-(4-chlorophenyl)ethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other names: spirochlorphine; R-6890) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Temporary listing of substances subject to emergency scheduling

> (h) Temporary listing of substances subject to emergency scheduling.

**DEA code number:** 2778

**Temporary listing expires:** Mar. 16, 2028

> adding paragraph (h)(86), effective from Mar. 16, 2026, until Mar. 16, 2028

**CFR citation:** 21 CFR 1308.11(h)(86)

> (86) 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam) | 2778 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (Other name: bromazolam) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Acetorphine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opium derivatives

> (c) Opium derivatives.

**DEA code number:** 9319

**CFR citation:** 21 CFR 1308.11(c)(1)

> (1) Acetorphine | 9319 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Acetorphine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9815

**CFR citation:** 21 CFR 1308.11(b)(1)

> (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) | 9815 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9821

**CFR citation:** 21 CFR 1308.11(b)(3)

> (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Acetyldihydrocodeine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opium derivatives

> (c) Opium derivatives.

**DEA code number:** 9051

**CFR citation:** 21 CFR 1308.11(c)(2)

> (2) Acetyldihydrocodeine | 9051 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Acetyldihydrocodeine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Acetylmethadol

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9601

**CFR citation:** 21 CFR 1308.11(b)(2)

> (2) Acetylmethadol | 9601 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Acetylmethadol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9811

**CFR citation:** 21 CFR 1308.11(b)(4)

> (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl) | 9811 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9551

**CFR citation:** 21 CFR 1308.11(b)(5)

> (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) | 9551 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alfaxalone

**Schedule:** Schedule IV

> § 1308.14 Schedule IV.

**Listed under:** Depressants

> (c) Depressants.

**DEA code number:** 2731

**CFR citation:** 21 CFR 1308.14(c)(1)

> (1) Alfaxalone | 2731 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alfaxalone — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alfentanil

**Schedule:** Schedule II

> § 1308.12 Schedule II.

**Listed under:** Opiates

> (c) Opiates.

**DEA code number:** 9737

**CFR citation:** 21 CFR 1308.12(c)(1)

> (1) Alfentanil | 9737 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alfentanil — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Allylprodine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9602

**CFR citation:** 21 CFR 1308.11(b)(6)

> (6) Allylprodine | 9602 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Allylprodine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alpha-ethyltryptamine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7249

**CFR citation:** 21 CFR 1308.11(d)(1)

> (1) Alpha-ethyltryptamine | 7249 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alpha-ethyltryptamine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** alpha′-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9864

**CFR citation:** 21 CFR 1308.11(b)(10)

> (10) alpha′-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | 9864 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

alpha′-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9814

**CFR citation:** 21 CFR 1308.11(b)(11)

> (11) alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine) | 9814 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9832

**CFR citation:** 21 CFR 1308.11(b)(12)

> (12) alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) | 9832 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alpha-methyltryptamine (other name: AMT)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7432

**CFR citation:** 21 CFR 1308.11(d)(16)

> (16) Alpha-methyltryptamine (other name: AMT) | 7432 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alpha-methyltryptamine (other name: AMT) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** alpha-pyrrolidinobutiophenone (α-PBP)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7546

**CFR citation:** 21 CFR 1308.11(d)(68)

> (68) alpha-pyrrolidinobutiophenone (α-PBP) | (7546) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

alpha-pyrrolidinobutiophenone (α-PBP) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7548

**CFR citation:** 21 CFR 1308.11(d)(98)

> (98) alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) | 7548 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

alpha-Pyrrolidinoheptaphenone (Other names: PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** alpha-Pyrrolidinohexanophenone (Other names: α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7544

**CFR citation:** 21 CFR 1308.11(d)(95)

> (95) alpha-Pyrrolidinohexanophenone (Other names: α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) | 7544 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

alpha-Pyrrolidinohexanophenone (Other names: α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** alpha-pyrrolidinopentiophenone (α-PVP)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Hallucinogenic substances

> (d) Hallucinogenic substances.

**DEA code number:** 7545

**CFR citation:** 21 CFR 1308.11(d)(61)

> (61) alpha-pyrrolidinopentiophenone (α-PVP) | (7545) |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

alpha-pyrrolidinopentiophenone (α-PVP) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9603

**CFR citation:** 21 CFR 1308.11(b)(7)

> (7) Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) | 9603 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alphameprodine

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9604

**CFR citation:** 21 CFR 1308.11(b)(8)

> (8) Alphameprodine | 9604 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alphameprodine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alphamethadol

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Opiates

> (b) Opiates.

**DEA code number:** 9605

**CFR citation:** 21 CFR 1308.11(b)(9)

> (9) Alphamethadol | 9605 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alphamethadol — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alphaprodine

**Schedule:** Schedule II

> § 1308.12 Schedule II.

**Listed under:** Opiates

> (c) Opiates.

**DEA code number:** 9010

**CFR citation:** 21 CFR 1308.12(c)(2)

> (2) Alphaprodine | 9010 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alphaprodine — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Alprazolam

**Schedule:** Schedule IV

> § 1308.14 Schedule IV.

**Listed under:** Depressants

> (c) Depressants.

**DEA code number:** 2882

**CFR citation:** 21 CFR 1308.14(c)(2)

> (2) Alprazolam | 2882 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Alprazolam — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Stimulants

> (f) Stimulants.

**DEA code number:** 1219

**CFR citation:** 21 CFR 1308.11(f)(1)

> (1) Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) | 1219 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) — Federal controlled substance schedule (I-V) by drug, with DEA code number


**Substance:** Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)

**Schedule:** Schedule I

> § 1308.11 Schedule I.

**Listed under:** Stimulants

> (f) Stimulants.

**DEA code number:** 1585

**CFR citation:** 21 CFR 1308.11(f)(2)

> (2) Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) | 1585 |

Source: <https://www.ecfr.gov/current/title-21/chapter-II/part-1308>

Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) — Federal controlled substance schedule (I-V) by drug, with DEA code number